Revlimid: 25 Cents for Production, 1000 Dollars in Sale

What the price policy of the pharmaceutical industry means for those who are dependent on expensive drugs is described by journalist David Armstrong on ProPublica, a non-profit online newsroom that has recently received the Pulitzer Prize for one of the published articles. Armstrong is treated for a multiple myeloma, a rare cancer, with "revlimid". The drug is used worldwide against multiple myeloma, a blood cancer "which devastates bones and le…